ASIA PACIFIC INTRAUTERINE CONTRACEPTIVE DEVICE MARKET FORECAST 2017-2025

ASIA PACIFIC INTRAUTERINE CONTRACEPTIVE DEVICE MARKET FORECAST 2017-2025

  • October 2017 •
  • 110 pages •
  • Report ID: 5147406
KEY FINDINGS
The Asia-Pacific intrauterine contraceptive device market was valued at $1274 million in 2016. The market is anticipated to rise with a CAGR of 4.20%, generating $1832 million over the forecast period of 2017-2025.

MARKET INSIGHTS
The market is segmented by type and by product. Presently, the copper IUCD market holds a major share of the market. The market is fast gaining momentum in the Asia-Pacific region for applications like birth control or for preventing endometrial malignancy issues like squamous or adenosquamous cell carcinoma. China is expected to be the biggest contributor to this market. The Chinese market is chiefly being driven by the various awareness initiatives undertaken by the schools and other educational institutions regarding the benefits of IUD to avoid unwanted teen pregnancy.

COMPETITIVE INSIGHTS
Allergan Plc, Zhejiang Daji Medical Instruments Co Ltd, HLL Lifecare Limited, Bayers Ag, Ocon Medical Ltd, Krishco Medical Products Pvt.Ltd, Okamoto Industries, Pfizer, Medisafe Distribution Inc, Teva Pharmaceutical Industries Limited, and Meril Life Sciences Private Limited are some of the noted companies in the region.
Country=APAC Date=201710 Publisher=InkwoodResearch Price=2000